Welcome
The 4th Biomarkers of the Future Conference: 15-16 November 2022
The BMF 2022 Virtual platform is now open.
You can access the BMF 22 virtual platform from now. Visit the platform to learn more about the speakers, program and view and vote on the Young Researchers e-Posters.
LATEST NEWS
Breaking: DEADLINE TO SEND YOUR ABSTRACT FOR THE YOUNG RESEARCHER COMPETITION EXTENDED TO THURSDAY 3 NOVEMBER
✍️
Breaking: DEADLINE TO SEND YOUR ABSTRACT FOR THE YOUNG RESEARCHER COMPETITION EXTENDED TO THURSDAY 3 NOVEMBER ✍️
Meet the faculty
Latest additions: Yang De Marinis (SWE), Robert Mentz (USA), Luis Ruilope (ESP), Nancy Ip (HKG), Thibaud Damy (FRA)
✵
Latest additions: Yang De Marinis (SWE), Robert Mentz (USA), Luis Ruilope (ESP), Nancy Ip (HKG), Thibaud Damy (FRA) ✵
Dear Colleagues,
It is our pleasure to invite you to the 4th edition of the Biomarkers of the Future Conference, taking place virtually on 15-16 November, 2022.
Interview with Professor Alexandre Mebazaa, from the BMF 2022 scientific committee.
Following the success of the past 3 editions of the Biomarker Meeting of the Future, the BMF 2022 will bring together a number of international key opinion leaders, all experts within in their individual fields of life science research, along with young fellows, senior researchers and industry partners, all focusing on biomarker discovery and research. The meeting will be directed to the application of high-throughput targeted proteomics as a key tool to understand biology and pathophysiology, as well as identify protein biomarkers for early diagnosis and progression of our major complex diseases.
Today tools are needed for high-throughput protein screening which provide much more powerful and reliable tool than just looking at a single protein at a time. Studying thousands of proteins simultaneously without losing in specificity or sensitivity, in extremely small amounts of liquid biopsy samples has become possible with the use of high-multiplex immunoassay panels. Protein biomarker profiles can also help stratifying patients, identifying predictive markers to monitor response to treatment and serve as tools for selecting the optimal therapy to the right patient.
The conference will take place online using a custom-made, state-of-the-art platform to maintain the high quality scientific content, the networking opportunities and the young fellows competition.
It will be accessible and free of charge to academics, researchers, young fellows and industry participants.
Registration is now open.
For further information, please reach out to us on biomarkers.future@overcome.eu.
Please do not hesitate to share with your colleagues.
With our best wishes,
Professor Alexandre Mebazaa
Paris - France
